ESR1 and breast carcinoma: To investigate the genome evolution through breast cancer progression, successive tumor samples from an estrogen receptor positive, HER2-negative breast cancer patient undergoing mastectomy and an asynchronous metastasis were collected and thoroughly analyzed using next generation sequencing.